HOLOGIC specialises in women’s health and laboratory technologies, offering comprehensive solutions across multiple medical categories.​

Core Product Categories

Women’s Health Solutions:

  • Breast Health: Risk assessment, screening/diagnosis, biopsy, localisation/marking, specimen pathology, radiography, metabolic health
  • Gynaecological Health: Hysteroscopic surgery, endometrial ablation, perinatal health, sexual health, vaginal health
  • Sexual Health: Dedicated sexual and vaginal health products plus collection devices
  • Skeletal Health: Bone density and skeletal assessment tools

Laboratory Technologies:

  • Diagnostic Tests: Respiratory, gastrointestinal, STI, virology, transplant, vaginal health, hospital-acquired infections, HPV, perinatal health, lab-developed tests
  • Molecular Diagnostics: High-throughput testing across multiple disease categories
  • Cytology: Traditional and digital cytology with HPV integration
  • Screening Technologies: High-throughput cytology, digital cytology, HPV, respiratory, STI screening
  • Collection Devices: Specialised sample collection systems

The company provides end-to-end solutions for clinical diagnostics, surgical interventions, and preventive screening with global reach across 15+ countries

 

1. BREAST HEALTH SOLUTIONS

Hologic offers a comprehensive suite of breast health products designed for accurate detection, diagnosis, and treatment of breast cancer – the leading cancer among women globally.

 

1.1 – Selenia® Dimensions® Digital Mammography System

 

 

 

https://www.youtube.com/watch?v=3V-M1C9zJ9k

 

The Hologic Selenia Dimensions system is a leading-edge 3D mammography platform designed to detect significantly more invasive breast cancers earlier than traditional 2D mammography. It enhances clinical confidence and workflow efficiency through superior ergonomics and advanced imaging technology.

Key Features and Benefits:

  • Genius™ 3D Mammography Exam: Clinically proven to detect 20-65% more invasive breast cancers, reducing unnecessary recalls and biopsies, thereby improving patient outcomes and clinical efficiency.
  • 3D Tomosynthesis Technology: Creates a three-dimensional view of the breast to eliminate overlapping tissue, which increases accuracy in detecting small tumors and distinguishing benign from malignant lesions.
  • Low Dose Radiation: Utilizes low-dose imaging compared to conventional methods, ensuring patient safety without compromising image quality.
  • Advanced Image Clarity: High-resolution imaging improves lesion visibility, supporting earlier diagnosis.
  • Large Source-to-Image Distance (SID) of 70 cm: Provides ample room for comfortable patient positioning and flexibility during interventional procedures.
  • Ergonomic Design: Features such as a retractable face shield and adjustable height table improve patient comfort during exams and reduce operator fatigue.
  • Flexible Configurations: Available in multiple system packages tailored for screening, diagnostic, and interventional needs, including mobile mammography options.
  • C-View™ Technology: Generates synthesized 2D images from 3D data, reducing the need for additional 2D exposures and minimizing patient compression time.
  • Streamlined Workflow: Touchscreen controls and intuitive software reduce exam times and increase throughput.
  • Enhanced Diagnostic Workstation Support: The SecurView® DX diagnostic workstation accompanies the system with customized workflow tools, enabling efficient interpretation of 2D and 3D images.
  • Biometric Login & User Profiles: Ensures data security and speeds up patient and technologist setup.
  • Integration with Affirm™ Breast Biopsy System: Enables seamless transitions between screening and biopsy procedures.

Clinical Advantages:

  • Improves early cancer detection rates, potentially saving more lives. Earlier detection of breast cancer at more treatable stages
  • Significantly reduces false-positive recalls compared to traditional mammography. Reduced false positives and repeat imaging
  • Enhances patient compliance with a more comfortable exam experience. Enhanced patient confidence and compliance
  • Significant improvement in diagnostic accuracy rates
  • Supports a comprehensive breast health program with support for screening, diagnosis, and intervention.

The Selenia Dimensions system is a future-proof platform with upgrade capabilities to adapt to evolving technological and clinical needs, helping healthcare providers deliver excellence in breast cancer diagnosis and care.

Target Institutions:

  • Multi-specialty hospitals with radiology departments
  • Cancer diagnostic centers
  • Imaging clinics and breast health screening facilities
  • Medical colleges and academic hospitals offering breast imaging programs

 

 

1.2 – Hologic Affirm® Prone Breast Biopsy System

 

 

https://www.youtube.com/watch?v=YTvB0vxzSP8

 

The Hologic Affirm® Prone Breast Biopsy System is the first dedicated prone stereotactic biopsy platform supporting both 2D and 3D tomosynthesis-guided procedures, enabling precise targeting of lesions detected during mammography screening.​

Designed for superior patient comfort, it features a prone positioning table that eliminates direct needle visibility, reduces procedure times by up to 40%, and provides 360° breast access via a fully integrated C-arm with lateral needle approach for challenging lesions.​

Equipped with advanced imaging from the same detector technology as Hologic’s Selenia Dimensions mammography system, it offers exceptional image quality for subtle lesions and calcifications while streamlining workflows with automated features and daily QC.

This system enhances diagnostic confidence and efficiency in breast screening programs across medical facilities.

Key System Features

  • Advanced 2D/3D™ Imaging Technology: Utilizes the same proven direct-conversion selenium detector as Hologic’s Selenia® Dimensions® mammography system, delivering exceptional image quality for subtle lesions and faint calcifications with a large 14.3 cm x 11.7 cm field of view—over 6.5 times larger than existing dedicated prone systems​
  • X-ray Translucent Paddles: Enable broad visualization of targeted tissue while maintaining high-resolution 2D and 3D™ images during compression​
  • Fully Integrated C-arm Design: Provides 360° breast access with 180° C-arm rotation and bidirectional patient positioning, accommodating challenging lesion locations including axillary regions​
  • Innovative Lateral Needle Approach: Exclusive fully integrated lateral access without additional accessories or releasing compression, ideal for thin breasts and difficult lesions​
  • Automated Tube-Head Motion: Single-button sweep acquires all necessary images in seconds, streamlining stereotactic targeting and reducing procedure times​
  • One-Click 3D™ Targeting: Intuitive software interface based on Selenia Dimensions platform simplifies tomosynthesis-guided biopsies​
  • Programmed Needle Parameters: Automated real-time calculations display safety margins and distances, eliminating manual computations and reducing errors​
  • Touchscreen Biopsy Control Module: Clearly displays biopsy device position throughout procedures for enhanced precision​

 

 

1.3 –  Affirm® Contrast Biopsy Software

Product Overview:

Affirm Contrast Biopsy Software enhances the capability of Selenia Dimensions systems by providing contrast-enhanced imaging, a revolutionary advancement in breast cancer diagnosis.

Key Features:

  • Contrast-Enhanced Technology: Uses IV contrast to highlight areas of breast cancer concern
  • Increased Specificity: Reduces biopsy of benign lesions by identifying malignant characteristics
  • Precision Guidance: Provides accurate localization for biopsy procedures
  • Seamless Integration: Works with existing Selenia Dimensions infrastructure

Clinical Advantages:

  • Fewer unnecessary biopsies
  • Improved positive predictive value
  • Enhanced diagnostic confidence
  • Streamlined patient pathways

 

 

1.4 –  Brevera® Breast Biopsy System

 

https://youtu.be/W9omp1TgaMw?si=8vlfgktUPUmHifLd

 

Product Overview:

The Brevera system is an advanced ultrasound-guided breast biopsy platform enabling minimally invasive tissue diagnosis.

Key Features:

  • Ultrasound Guidance: Real-time imaging for precise needle placement
  • Vacuum-Assisted Technology: Efficient tissue sampling with minimal trauma
  • High Sample Yield: Optimal tissue specimens for accurate pathology
  • Patient Comfort: Minimally invasive approach with reduced patient discomfort
  • Fast Results: Streamlined workflow enabling rapid diagnosis

Clinical Applications:

  • Diagnosis of suspicious breast lesions
  • Differentiation between benign and malignant findings
  • Tissue confirmation prior to surgical intervention

 

 

1.5 –  LOCalizer™ Wire-Free Guidance System

Product Overview:

LOCalizer is a revolutionary wire-free localization system that replaces traditional wire-guided localization for breast surgery.

Key Features:

  • Radiofrequency Technology: Wireless guidance system eliminating need for placement wire
  • Enhanced Accuracy: Precise lesion localization intraoperatively
  • Improved Workflow: Reduces time between localization and surgery
  • Reduced Patient Anxiety: No pre-operative wire placement discomfort
  • Surgical Efficiency: Clearer lesion identification for surgeons

Surgical Advantages:

  • Shorter operative times
  • Improved cosmetic outcomes
  • Enhanced diagnostic accuracy of excised specimens
  • Better patient experience

 

 

1.6 Faxitron® Trident® HD Specimen Radiography System

https://www.youtube.com/watch?v=Vf2E5qZcl7E

 

Product Overview:

The Faxitron Trident provides high-definition specimen imaging for intraoperative assessment of breast surgical specimens.

Key Features:

  • High-Resolution Imaging: Digital radiography providing clear visualization of excised tissue
  • Real-Time Assessment: Immediate intraoperative evaluation enabling complete lesion excision confirmation
  • Rapid Processing: Fast image acquisition and reporting
  • Quality Assurance: Ensures complete removal of lesions during surgery

Quality Control Benefits:

  • Confirms complete lesion excision
  • Reduces re-excision rates
  • Ensures specimen adequacy for pathology
  • Improves surgical outcomes

 

2: Gynecological Health Solutions

Hologic’s gynecological product suite provides innovative solutions for minimally invasive surgical interventions addressing common gynecological conditions.

 

2.1 – NovaSure® Endometrial Ablation System

NovaSure Endometrial Ablation – Minimally Invasive Solution

Product Overview:

NovaSure is the leading minimally invasive treatment for abnormal uterine bleeding (AUB), providing a safe alternative to hysterectomy.

Key Features:

  • Radiofrequency Ablation: Uses bipolar radiofrequency energy to ablate endometrial lining
  • SmartDepth™ Technology: Physiological endpoint sensing preventing excessive tissue penetration
  • Quick Procedure: Average treatment time of 5-10 minutes
  • One-Time Treatment: Permanent solution to abnormal bleeding
  • Minimal Recovery: Outpatient procedure with rapid return to normal activities

Clinical Benefits:

  • Treats abnormal uterine bleeding in 80-90% of patients
  • Significantly reduces menstrual blood flow
  • Amenorrhea (cessation of menstruation) in 30-50% of patients
  • Avoids hysterectomy and its associated morbidity
  • Improved quality of life and patient satisfaction

Indications:

  • Heavy menstrual bleeding (menorrhagia)
  • Prolonged menstrual bleeding (menometrorhagia)
  • Dysmenorrhea management
  • Alternative to hysterectomy

 

2.2 –  MyoSure® Hysteroscopic Surgery System

MyoSure Hysteroscopic Fibroid Removal System

Product Overview:

MyoSure is an innovative mechanical hysteroscopic system for removal of uterine fibroids, polyps, and tissue abnormalities without traditional surgical approaches.

Key Features:

  • Mechanical Resection: Rotating blade technology efficiently removes fibroids and polyps
  • Tissue Aspiration: Integrated suction system removes tissue debris
  • Real-Time Visualization: Clear hysteroscopic view of operative field
  • Minimal Tissue Trauma: Precise removal without excessive collateral damage
  • Fast Operative Time: Efficient tissue removal
  • Outpatient Procedure: Minimally invasive approach

Clinical Applications:

  • Submucosal Fibroids: Effective removal of intracavitary myomas
  • Endometrial Polyps: Complete polypectomy
  • Retained Products of Conception: Post-abortion tissue removal
  • Uterine Septum Resection: Reproductive surgery
  • Abnormal Uterine Bleeding: Tissue ablation

Surgical Advantages:

  • Preserves uterus (important for fertility and patient preference)
  • Minimal blood loss compared to hysterectomy
  • Short operative time and hospital stay
  • Rapid patient recovery
  • Excellent patient satisfaction

 

3: Molecular Diagnostics & Laboratory Solutions

Hologic’s laboratory diagnostics portfolio provides comprehensive solutions for infectious disease screening, molecular testing, and advanced pathology.

 

3.1 – Panther Fusion® Molecular Diagnostics System

https://www.youtube.com/watch?v=pwBgjBLZnjQ

 

Product Overview:

Panther Fusion is an automated, high-throughput molecular diagnostics platform providing rapid, accurate detection of infectious agents.

Key Features:

  • Fully Automated Workflow: Sample-to-result automation reducing manual steps
  • High-Throughput Capacity: Tests hundreds of samples daily
  • Multiple Assay Options: Flexible platform supporting diverse test menus
  • Rapid Turnaround Time: Results within hours for critical testing
  • Advanced Quality Control: Built-in system monitoring and quality assurance
  • Easy Integration: Seamless laboratory information system connectivity

Comprehensive Test Menu:

  • Respiratory Pathogens: SARS-CoV-2, Influenza A/B, RSV, and combination assays
  • Sexually Transmitted Infections (STI): Chlamydia trachomatis, Neisseria gonorrhoeae
  • Gastrointestinal Pathogens: Bacterial identification and resistance profiling
  • HPV Testing: Human papillomavirus detection and genotyping
  • Transplant Diagnostics: CMV, EBV monitoring
  • Hospital-Acquired Infection Monitoring: Rapid detection of nosocomial pathogens

Laboratory Benefits:

  • Increased diagnostic throughput
  • Improved turnaround times
  • Enhanced diagnostic accuracy
  • Reduced operational costs per test
  • Supports public health surveillance

Target Institutions:

  • Hospital central laboratories
  • Diagnostic reference laboratories
  • Medical college pathology departments
  • Public health laboratories

 

3.2 – Genius™ Digital Diagnostics System (AI-Based Cytology)

 

https://www.youtube.com/watch?v=hU4W7HgvPBI

 

Product Overview:

Genius is the first cytology solution incorporating artificial intelligence and volumetric imaging for cervical cancer screening and diagnosis. This breakthrough technology represents a paradigm shift in cervical pathology.

Key Features:

  • Artificial Intelligence: Advanced machine learning algorithms assist in cell classification
  • Volumetric Imaging: 3D visualization of cell samples enabling comprehensive assessment
  • Digital Cytology: Complete digitalization of cytology workflow
  • Automated Screening: AI-assisted analysis of cervical samples
  • High Sensitivity & Specificity: Improved detection of precancerous and cancerous cells
  • Workflow Optimization: Reduces manual screening time
  • Quality Assurance: Built-in quality control mechanisms

Clinical Advantages:

  • Early cervical cancer detection
  • Improved diagnostic accuracy compared to manual screening
  • Reduced screening time and labor requirements
  • Enhanced reproducibility and consistency
  • Support for resource-constrained settings

Screening Applications:

  • Cervical cancer prevention programs
  • Pap smear analysis
  • HPV-based screening protocols
  • Liquid-based cytology assessment
  • Quality control and proficiency testing

Public Health Impact:

  • Supports national cervical cancer screening initiatives
  • Enables efficient screening in medical colleges
  • Reduces diagnostic delays
  • Improves cancer prevention outcomes

 

3.3 – Aptima® Combo 2 Assay (CT/NG Detection)

Product Overview:

Aptima Combo 2 is a nucleic acid amplification test (NAAT) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Key Features:

  • Dual Detection: Simultaneous detection of two major STI pathogens
  • High Sensitivity & Specificity: Superior diagnostic accuracy
  • Multiple Specimen Types: Urine, urethral, cervical, rectal specimens
  • Rapid Results: Quick turnaround time for clinical decision-making
  • Standardized Reporting: Clear, actionable results

Clinical Benefits:

  • Efficient STI screening
  • Supports disease surveillance
  • Enables rapid treatment initiation
  • Reduces complications from untreated infections

 

3.4 Aptima® HPV Assays

Product Overview:

Comprehensive HPV detection and genotyping assays for cervical cancer prevention and monitoring.

Key Features:

  • HPV Genotyping: Detection of high-risk and low-risk HPV types
  • Liquid-Based Cervical Samples: Compatible with modern screening methodologies
  • Risk Stratification: Supports clinical decision-making for colposcopy referrals
  • Quality Testing: High reproducibility and accuracy

Clinical Applications:

  • Cervical cancer screening programs
  • HPV vaccination follow-up
  • Monitoring of abnormal Pap smears
  • Primary HPV screening protocols

 

4: Cytology Solutions

4.1 – Complete Cytology Solution Suite

Hologic offers a comprehensive cytology solution integrating specimen collection, processing, digital analysis, and interpretation support.

Product Components:

  • Collection Devices – Optimized specimen preservation
  • Processing Systems – Automated slide preparation
  • Digital Cytology Platform – Image acquisition and analysis
  • AI-Assisted Screening – Genius system for quality control
  • Quality Assurance Tools – Proficiency testing and metrics

Benefits to Laboratories:

  • Streamlined cytology workflow from collection to reporting
  • Improved specimen quality and consistency
  • Reduced turnaround times
  • Enhanced diagnostic accuracy
  • Comprehensive quality metrics and compliance